Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

G-Zero Therapeutics receives NIH grant for studies in radiation exposure

Oct. 5, 2011

Nanotherapeutics receives U.S. government contract to develop oral radiation drug

Oct. 4, 2011

OX-219 shows promise in patients with opioid dependence

Sep. 22, 2011

Rare Disease Therapeutics selects distributor for Anascorp

Sep. 15, 2011

Pluristem's PLX cells show promise in preclinical studies

Sep. 9, 2011

BioDelivery Sciences reports preliminary phase I data on BEMA-buprenorphine/naloxone

Sep. 7, 2011

Duloxetine blocks psychostimulant effects

Sep. 5, 2011

Titan Pharmaceuticals schedules pre-NDA meeting for Probuphine

Sep. 1, 2011

ALL-00179 allows transdermal delivery of cannabidiol with microneedles

Aug. 22, 2011

PharmAthene receives Department of Defense contract for nerve agent medical countermeasure program

Aug. 17, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...